Role of stereotactic ablative radiotherapy for primary renal cell carcinoma

This paper reviews the use of stereotactic ablative radiotherapy (SABR) (also called stereotactic body radiotherapy, SBRT) for treating primary renal cell carcinoma (RCC) that cannot be removed with surgery. SABR is a treatment that automatically targets high doses of radiotherapy to the tumour with high precision. SABR is very accurate, and thereby maximises the cell-killing […]

read more

Role of stereotactic ablative radiotherapy (SABR) for kidney cancer

This systematic review and meta-analysis of the literature for the use of stereotactic ablative radiotherapy (SABR) for renal cell carcinoma (RCC), looks at data from 372 patients (383 tumours), most of whom were inoperable. The study concluded that renal SABR is effective locally and is well tolerated for primary RCC, despite treatment of larger tumours […]

read more

ASTRO 2018: Stereotactic radiotherapy proves safe and effective for kidney cancer patients with one kidney

The results from a study shows stereotactic ablative radiotherapy (SABR) for renal cell carcinoma (RCC) has been proven to be as safe and effective for RCC patients with one kidney as for those with two kidneys. This study is the result of an analysis of the largest international dataset of solitary kidney patients to be […]

read more

Stereotactic body radiotherapy may improve control of localised kidney cancer

A recent study published in The Journal of Urology¬†this month suggests that stereotactic body radiotherapy (SBRT) may be a safe and effective therapeutic option that could control the growth of localised, small numbers of metastases (oligometastatic) in people with advanced renal cell carcinoma (RCC). Fifty-eight RCC patients, who had undergone surgery and had a maximum […]

read more

Stereotactic radiotherapy for metastatic kidney cancer

A paper published in the European Journal of Cancer earlier this month reports on the experience of six French hospitals with stereotactic radiotherapy (SRT) for metastatic renal cell carcinoma (RCC) between 2008 and 2015 . This retrospective study showed a 12-month local control rate of metastases of 82.9%. Twenty-five percent of patients with oligometastatic disease […]

read more

Stereotactic radiotherapy for the treatment of metastatic renal cell carcinoma

Results from a recent retrospective study from France, published in the journal Oncology,¬†have shown that stereotactic radiotherapy is safe and effective for metastatic renal cell carcinoma (RCC) patients with metastases in one or two other parts of the body (oligometastatic or oligoprogressive). Stereotactic radiotherapy may also delay the start or change of systemic (drug) therapy. […]

read more

Stereotactic ablative radiotherapy (SABR) is an effective treatment for primary kidney cancer

Data from a pooled analysis published in the journal Cancer recently, shows that stereotactic ablative radiotherapy (SABR) can effectively treat patients with primary renal cell carcinoma (RCC), whilst preserving renal function. In this study, data from 233 people with RCC who had undergone SABR treatment were pooled; 118 patients received single-fraction SABR and 105 received […]

read more

Stereotactic radiotherapy is a promising treatment for kidney cancer patients

Research carried out by the University of Texas Southwestern Medical Center in America has demonstrated that stereotactic radiotherapy is an effective treatment for people with kidney cancer. The research showed that stereotactic radiotherapy treatment had 90% control over the growth of kidney tumours. The researchers suggest this finding could potentially lead to the possibility of […]

read more

Role of stereotactic ablative radiotherapy in metastatic kidney cancer

Radiotherapy is generally only used in advanced kidney cancer for the treatment of metastases in a select number of cases. However, the use of stereotactic ablative radiotherapy (SABR) offers promise for the treatment of metastatic spread of kidney cancer to different locations in the body. An expert in the field discussed the present situation with […]

read more
Showing all 9 results
  TOP